10x Genomics Inc (NASDAQ:TXG) has a beta value of 2.01 and has seen 2.46 million shares traded in the last trading session. The company, currently
10x Genomics Inc (NASDAQ:TXG) has a beta value of 2.01 and has seen 0.53 million shares traded in the recent trading session. The company, currently
During the last session, 10x Genomics Inc (NASDAQ:TXG)’s traded shares were 3.84 million, with the beta value of the company hitting 1.99. At the end
In the last trading session, 3.22 million shares of the 10x Genomics Inc (NASDAQ:TXG) were traded, and its beta was 1.97. Most recently the company’s
10x Genomics Inc (NASDAQ:TXG)’s traded shares stood at 4.05 million during the last session, with the company’s beta value hitting 1.95. At the close of
In the last trading session, 2.79 million 10x Genomics Inc (NASDAQ:TXG) shares changed hands as the company’s beta touched 1.93. With the company’s per share
In last trading session, 10x Genomics Inc (NASDAQ:TXG) saw 2.49 million shares changing hands with its beta currently measuring 1.89. Company’s recent per share price
10x Genomics Inc (NASDAQ:TXG) has a beta value of 1.93 and has seen 0.52 million shares traded in the recent trading session. The company, currently
During the last session, 10x Genomics Inc (NASDAQ:TXG)’s traded shares were 4.34 million, with the beta value of the company hitting 1.97. At the end
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
